Introduction: Treatment and prevention are of critical importance in patients with cutaneous lupus erythematosus (CLE), as the disease can have a devastating effect on patient well-being and quality of life. Areas Covered: We conducted a selective search of the PubMed database for articles published between December 2010 and November 2015. This review encompasses both non-pharmaceutical (photoprotection, smoking cessation, drug withdrawal, and vitamin D replacement) and pharmaceutical (topicals, antimalarials, immunosuppressives, biologics, etc.) interventions used in the treatment of CLE. Expert Commentary: Recent work has expanded our understanding of established therapies as well as introduced new treatments for consideration, though existing medications still prove inadequate for a subset of patients. Changes in trial design may help to alleviate this issue.
|Title of host publication||Expert Review of Clinical Immunology|
|Place of Publication||V.P. Werth, Department of Dermatology, Perelman Center for Advanced Medicine, Philadelphia, United States|
|Number of pages||13|
|Publication status||Published - 2016|
|Name||Expert Review of Clinical Immunology|
Chang, J., & Werth, V. P. (2016). Therapeutic options for cutaneous lupus erythematosus: recent advances and future prospects. In Expert Review of Clinical Immunology (pp. 1109-1121). (Expert Review of Clinical Immunology; Vol. 12).. https://doi.org/10.1080/1744666X.2016.1188006